Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BCL7A is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. Additionally we are shipping B-Cell CLL/lymphoma 7A Antibodies (49) and B-Cell CLL/lymphoma 7A Proteins (8) and many more products for this protein.
Data suggest that BCL7A may play an important role in cutaneous T-cell lymphoma (CTCL (show TSPYL2 ELISA Kits)) carcinogenesis.
Report describes BCL7A protein expression in normal lymphoid tissues and lymphomas using immunohistochemistry.
Promoter hypermethylation of BCL7a is associated with cutaneous T-cell lymphoma
deletion of genes BCL7A in early-stage mycosis fungoides.
Variants in BCL7A were strongly related to diffuse large B-cell lymphoma.
This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.
B-cell CLL/lymphoma 7A
, B-cell CLL/lymphoma 7 protein family member A
, B-cell CLL/lymphoma-7